insitro is a machine-learning-driven drug discovery and development company founded in 2018 by Daphne Koller and headquartered in South San Francisco, California. It combines large-scale in vitro cellular data generated in its own automated labs with human clinical and genetic data to build predictive models of biology, aiming to bring better drugs faster to the patients most likely to benefit. Its therapeutic focus spans metabolism, oncology, and neuroscience, and its interdisciplinary teams pair life scientists, data scientists, and engineers. insitro operates no public developer API; it maintains open-source research and infrastructure tooling (such as the redun workflow engine) on its GitHub organization. Backed by a16z, GV, and the SoftBank Vision Fund.
insitro is profiled on the APIs.io network. Tagged areas include Company, Drug Discovery, Machine Learning, Biotechnology, and Life Sciences.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/insitro: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: insitro
name: insitro
description: insitro is a machine-learning-driven drug discovery and development company founded in 2018 by Daphne Koller
and headquartered in South San Francisco, California. It combines large-scale in vitro cellular data generated in its own
automated labs with human clinical and genetic data to build predictive models of biology, aiming to bring better drugs
faster to the patients most likely to benefit. Its therapeutic focus spans metabolism, oncology, and neuroscience, and its
interdisciplinary teams pair life scientists, data scientists, and engineers. insitro operates no public developer API;
it maintains open-source research and infrastructure tooling (such as the redun workflow engine) on its GitHub organization.
Backed by a16z, GV, and the SoftBank Vision Fund.
url: https://raw.githubusercontent.com/api-evangelist/insitro/refs/heads/main/apis.yml
deliveryModel:
model: library
open_source: false
commercial: false
callable_host: false
label: Library · distributed through package registries, no callable service
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://www.insitro.com/wp-content/uploads/2023/11/logo-insitro.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- gv
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-10-06'
tags:
- Company
- Drug Discovery
- Machine Learning
- Biotechnology
- Life Sciences
- Genomics
- Pharmaceuticals
- Artificial Intelligence
tags_raw:
- Company
- Drug Discovery
- Machine Learning
- Biotechnology
- Life Sciences
- Genomics
- Pharmaceuticals
- Artificial Intelligence
- Machine-Learning
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- url: https://www.insitro.com/feed/
type: BlogRSS
- type: Website
url: https://www.insitro.com
- type: GitHubOrganization
url: https://github.com/insitro
- type: PrivacyPolicy
url: https://www.insitro.com/privacy-policy/
- type: Careers
url: https://www.insitro.com/join-us/
- type: Packages
url: packages/insitro-packages.yml
- type: WellKnown
url: well-known/insitro-well-known.yml
- type: SecurityTxt
url: well-known/insitro-security.txt
- type: DomainSecurity
url: security/insitro-domain-security.yml
- type: VulnerabilityDisclosure
url: security/insitro-vulnerability-disclosure.yml
- type: Security
url: well-known/insitro-security.txt
x-enrichment:
date: '2026-07-19'
status: backfilled
pass: local-v1
note: backfilled from .gitignore signal + verified work evidence
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.